Breast Reconstruction Augmentation Market Insights:
In a recent research report by Market Research Community, the breast reconstruction augmentation market is expected to surpass USD 827.9 Million by the year 2030, from USD 469.7 Million in 2021.
Breast reconstruction augmentation is a type of cosmetic procedure that provides increased volume and fullness of breasts using breast implants and silicone pads. The major goal of breast reconstruction augmentation surgery is to fulfill the demand of consumers for enhanced physical appearance through features such as size improvement of small breasts, correction of uneven breasts post surgeries, and overall satisfaction through a self-confidence boost.
The acellular dermal matrix segment is anticipated to boost the growth of the product type segment during the projected period. The factors such as precise control and support of the positioned implants, improved implant coverage, and reduced rate of capsular contracture are major factors that are expected to support the growth of the acellular dermal matrix segment during the forecast period.
Europe is expected to have the second-largest market share in the augmented breast reconstruction augmentation market growth in the forecast period. The factors such as increased research and development investments, rising technological advancements in medical devices, and growing demands for breast reconstructive augmentation surgeries are the major contributors to the growth of the breast reconstruction augmentation market in the European region.
The market is projected to grow at a significant pace reaching a CAGR of approximately 6.5%, over the forecast period of 2022–2030, despite a considerable fall in product sales during the initial phase of the pandemic spread and lockdown restrictions imposed globally.
The study is consolidated into major segments and further into sub-segments, such as by product (breast implants, tissue expanders, and acellular dermal matrix), by shape (round and anatomical), by end-use (hospitals, cosmetology clinics, ambulatory surgical centers), to forecast the market size by value; also includes the analysis of past market dynamics from 2016 – 2021, considering 2021 as the base year.
Lastly, the report includes a regional analysis and country analysis with the latest trends, along with the major key players including Johnson Johnson, Establishment Labs S.A., Integra LifeSciences, Allergan Inc., Sientra Inc., Ideal Implant Incorporated, POLYTECH Health Aesthetics GmbH, RTI Surgical Holdings, Sebbin, GC Aesthetics.
Our Recently Published Report:
Market Research Community